[1] GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020;8(6):585 − 96. https://doi.org/10.1016/S2213-2600(20)30105-3CrossRef
[2] Shi T, McAllister DA, O'Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet 2017;390(10098):946 − 58. https://doi.org/10.1016/S0140-6736(17)30938-8CrossRef
[3] Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med 2022;10(5):497 − 511. https://doi.org/10.1016/S2213-2600(21)00506-3CrossRef
[4] Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet 2017;389(10072):941 − 50. https://doi.org/10.1016/S0140-6736(17)30003-XCrossRef
[5] Shariq M, Sheikh JA, Quadir N, Sharma N, Hasnain SE, Ehtesham NZ. COVID-19 and tuberculosis: the double whammy of respiratory pathogens. Eur Respir Rev 2022;31(164):210264. https://doi.org/10.1183/16000617.0264-2021CrossRef
[6] Chandra M, Rana P, Chandra K, Arora VK. Tuberculosis - Depression syndemic: a public health challenge. Indian J Tuberc 2019;66(1):197 − 202. https://doi.org/10.1016/j.ijtb.2019.02.007CrossRef
[7] Fabbri LM, Celli BR, Agustí A, Criner GJ, Dransfield MT, Divo M, et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence. Lancet Respir Med 2023;11(11):1020 − 34. https://doi.org/10.1016/S2213-2600(23)00261-8CrossRef
[8] Dempsey TM, Scanlon PD. Pulmonary function tests for the generalist: a brief review. Mayo Clin Proc 2018;93(6):763 − 71. https://doi.org/10.1016/j.mayocp.2018.04.009CrossRef
[9] Hull JH, Lloyd JK, Cooper BG. Lung function testing in the COVID-19 endemic. Lancet Respir Med 2020;8(7):666 − 7. https://doi.org/10.1016/S2213-2600(20)30246-0CrossRef
[10] Jones PW, Quirk FH, Baveystock CM. The St george's respiratory questionnaire. Respir Med 1991;85 Suppl 2:25-31. http://dx.doi.org/10.1016/s0954-6111(06)80166-6.
[11] Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14(4):902 − 7. https://doi.org/10.1034/j.1399-3003.1999.14d2CrossRef
[12] Jones U. Chronic respiratory questionnaire. Thorax 1994;49(12):1277 − 8. https://doi.org/10.1136/thx.49.12.1277-aCrossRef
[13] Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MDL, Pavord ID. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003;58(4):339 − 43. https://doi.org/10.1136/thorax.58.4.339CrossRef
[14] Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305(6846):160 − 4. https://doi.org/10.1136/bmj.305.6846.160CrossRef
[15] Decramer M, Janssens W. Chronic obstructive pulmonary disease and comorbidities. Lancet Respir Med 2013;1(1):73 − 83. https://doi.org/10.1016/S2213-2600(12)70060-7CrossRef
[16] Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med 2009;7(4):357 − 63. https://doi.org/10.1370/afm.983CrossRef
[17] Griffiths EC, Pedersen AB, Fenton A, Petchey OL. Analysis of a summary network of co-infection in humans reveals that parasites interact most via shared resources. Proc Biol Sci 2014;281(1782):20132286. https://doi.org/10.1098/rspb.2013.2286CrossRef
[18] Eisenberg MD, Barry CL, Schilling CL, Kennedy-Hendricks A. Financial risk for COVID-19-like respiratory hospitalizations in consumer-directed health plans. Am J Prev Med 2020;59(3):445 − 8. https://doi.org/10.1016/j.amepre.2020.05.008CrossRef
[19] Budden KF, Shukla SD, Rehman SF, Bowerman KL, Keely S, Hugenholtz P, et al. Functional effects of the microbiota in chronic respiratory disease. Lancet Respir Med 2019;7(10):907 − 20. https://doi.org/10.1016/S2213-2600(18)30510-1CrossRef
[20] Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza. Lancet 2022;400(10353):693 − 706. https://doi.org/10.1016/S0140-6736(22)00982-5CrossRef
[21] Raaijmakers LHA, Schermer TR, Wijnen M, van Bommel HE, Michielsen L, Boone F, et al. Development of a person-centred integrated care approach for chronic disease management in dutch primary care: a mixed-method study. Int J Environ Res Public Health 2023;20(5):3824. https://doi.org/10.3390/ijerph20053824CrossRef
[22] Hardin M, Cho M, McDonald ML, Beaty T, Ramsdell J, Bhatt S, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J 2014;44(2):341 − 50. https://doi.org/10.1183/09031936.00216013CrossRef
[23] Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020;55(5):2000547. https://doi.org/10.1183/13993003.00547-2020CrossRef
[24] Dwyer-Lindgren L, Bertozzi-Villa A, Stubbs RW, Morozoff C, Shirude S, Naghavi M, et al. Trends and patterns of differences in chronic respiratory disease mortality among US counties, 1980-2014. JAMA 2017;318(12):1136 − 49. https://doi.org/10.1001/jama.2017.11747CrossRef
[25] Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J 2006;28(6):1245 − 57. https://doi.org/10.1183/09031936.00133805CrossRef
[26] Celli BR, Cote CG, Marin JM, Casanova C, De oca MM, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350(10):1005 − 12. https://doi.org/10.1056/NEJMoa021322CrossRef
[27] Gerald LB, Bailey WC. Global initiative for chronic obstructive lung disease. J Cardiopulm Rehabil 2002;22(4):234 − 44. https://doi.org/10.1097/00008483-200207000-00004CrossRef
[28] Mirza S, Clay RD, Koslow MA, Scanlon PD. COPD guidelines: a review of the 2018 GOLD report. Mayo Clin Proc 2018;93(10):1488 − 502. https://doi.org/10.1016/j.mayocp.2018.05.026CrossRef
[29] Nici L. Improving the lives of individuals with chronic respiratory disease: the need for innovation. Thorax 2022;77(7):636 − 7. https://doi.org/10.1136/thoraxjnl-2021-218318CrossRef
[30] Willis LD. Transition from pediatric to adult care for young adults with chronic respiratory disease. Respir Care 2020;65(12):1916 − 22. https://doi.org/10.4187/respcare.08260CrossRef
[31] García-Ortega A, Mora VM, Lobo JL. Respiratory comorbidity and pulmonary embolism. Arch Bronconeumol 2023;59(3):131 − 3. https://doi.org/10.1016/j.arbres.2022.09.009CrossRef
[32] Liu Q, Qin CY, Du M, Wang YP, Yan WX, Liu M, et al. Incidence and mortality trends of upper respiratory infections in China and other asian countries from 1990 to 2019. Viruses 2022;14(11):2550. https://doi.org/10.3390/v14112550CrossRef
[33] Tabor DE, Fernandes F, Langedijk AC, Wilkins D, Lebbink RJ, Tovchigrechko A, et al. Global molecular epidemiology of respiratory syncytial virus from the 2017-2018 INFORM-RSV study. J Clin Microbiol 2020;59(1):e01828 − 20. https://doi.org/10.1128/JCM.01828-20CrossRef
[34] Antón A, Marcos MA, Torner N, Isanta R, Camps M, Martínez A, et al. Virological surveillance of influenza and other respiratory viruses during six consecutive seasons from 2006 to 2012 in Catalonia, Spain. Clin Microbiol Infect 2016;22(6):564.e1 − 9. https://doi.org/10.1016/j.cmi.2016.02.007CrossRef
[35] Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity. Nat Rev Dis Primers 2022;8(1):48. https://doi.org/10.1038/s41572-022-00376-4CrossRef
[36] Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet 2002;359(9315):1373 − 8. https://doi.org/10.1016/S0140-6736(02)08350-2CrossRef
[37] Lavan AH, Gallagher PF, O'Mahony D. Methods to reduce prescribing errors in elderly patients with multimorbidity. Clin Interv Aging 2016;11:857 − 66. https://doi.org/10.2147/CIA.S80280CrossRef
[38] Gebreyohannes EA, Gebresillassie BM, Mulugeta F, Dessu E, Abebe TB. Treatment burden and health-related quality of life of patients with multimorbidity: a cross-sectional study. Qual Life Res 2023;32(11):3269 − 77. https://doi.org/10.1007/s11136-023-03473-3CrossRef
[39] McGill M, Blonde L, Chan JCN, Khunti K, Lavalle FJ, Bailey CJ, et al. The interdisciplinary team in type 2 diabetes management: challenges and best practice solutions from real-world scenarios. J Clin Transl Endocrinol 2016;7:21 − 7. https://doi.org/10.1016/j.jcte.2016.12.001CrossRef
[40] Shortell SM, Wu FM, Lewis VA, Colla CH, Fisher ES. A taxonomy of accountable care organizations for policy and practice. Health Serv Res 2014;49(6):1883 − 99. https://doi.org/10.1111/1475-6773.12234CrossRef
[41] WHO. The world health report 2008: primary health care now more than ever. 2008. https://iris.who.int/handle/10665/43949. [2023-12-20
[42] Mickan S, Hoffman SJ, Nasmith L. Collaborative practice in a global health context: common themes from developed and developing countries. J Interprof Care 2010;24(5):492 − 502. https://doi.org/10.3109/13561821003676325CrossRef
[43] O'Reilly P, Lee SH, O'Sullivan M, Cullen W, Kennedy C, MacFarlane A. Assessing the facilitators and barriers of interdisciplinary team working in primary care using normalisation process theory: an integrative review. PLoS One 2017;12(5):e0177026. https://doi.org/10.1371/journal.pone.0177026CrossRef
[44] Schutte DL, Kisting M, Warren C, Stoneman M. Linking hospitals to communities through evidence-based practice. Clin Nurse Spec 2022;36(5):249 − 53. https://doi.org/10.1097/NUR.0000000000000695CrossRef
[45] Rahman R, Matthews EB, Ahmad A, Rizvi SM, Salama U, Samad L, et al. Perceptions of patient-centred care among providers and patients in the orthopaedic department of a tertiary care hospital in Karachi, Pakistan. J Eval Clin Pract 2019;25(6):1160 − 8. https://doi.org/10.1111/jep.13242CrossRef
[46] Esper FP, Spahlinger T, Zhou L. Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease. J Infect 2011;63(4):260 − 6. https://doi.org/10.1016/j.jinf.2011.04.004CrossRef
[47] Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov 2018;17(1):35 − 56. https://doi.org/10.1038/nrd.2017.162CrossRef
[48] Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399(10325):629 − 55. https://doi.org/10.1016/S0140-6736(21)02724-0CrossRef
[49] Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020;26(12):1622 − 9. https://doi.org/10.1016/j.cmi.2020.07.016CrossRef
[50] Mazur NI, Martinón-Torres F, Baraldi E, Fauroux B, Greenough A, Heikkinen T, et al. Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics. Lancet Respir Med 2015;3(11):888 − 900. https://doi.org/10.1016/S2213-2600(15)00255-6CrossRef
[51] Radonovich LJ Jr, Simberkoff MS, Bessesen MT, Brown AC, Cummings DAT, Gaydos CA, et al. N95 respirators vs medical masks for preventing influenza among health care personnel. JAMA 2019;322(9):824. https://doi.org/10.1001/jama.2019.11645CrossRef
[52] Hall V, Foulkes S, Insalata F, Kirwan P, Saei A, Atti A, et al. Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection. N Engl J Med 2022;386(13):1207 − 20. https://doi.org/10.1056/NEJMoa2118691CrossRef
[53] Rochester CL, Spruit MA, Holland AE. Pulmonary rehabilitation in 2021. JAMA 2021;326(10):969 − 70. https://doi.org/10.1001/jama.2021.6560CrossRef
[54] Spruit MA, Singh SJ, Garvey C, Zuwallack R, Nici L, Rochester C, et al. An official American thoracic society/European respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188(8):e13 − 64. https://doi.org/10.1164/rccm.201309-1634STCrossRef
[55] Sethi S. Infection as a comorbidity of COPD. Eur Respir J 2010;35(6):1209 − 15. https://doi.org/10.1183/09031936.00081409CrossRef
[56] Spruit MA, Wouters EFM. Organizational aspects of pulmonary rehabilitation in chronic respiratory diseases. Respirology 2019;24(9):838 − 43. https://doi.org/10.1111/resp.13512CrossRef
[57] Leung JM, Niikura M, Yang CWT, Sin DD. COVID-19 and COPD. Eur Respir J 2020;56(2):2002108. https://doi.org/10.1183/13993003.02108-2020CrossRef
[58] Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2021;203(1):24-36. http://dx.doi.org/10.1164/rccm.202009-3533SO.